2019
DOI: 10.2147/ijn.s198848
|View full text |Cite
|
Sign up to set email alerts
|

<p>Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles</p>

Abstract: The implementation of nanotechnology in medicine has opened new research horizons particularly in the field of therapeutic delivery. Mesoporous silica particles have emerged as biocompatible drug delivery systems with an enormous potential in the treatment of cancer among many other pathologies. In this review, we focus on the unique properties of these particles as chemotherapy delivery carriers. Here, we summarize the general characteristics of these nanomaterials – including their physicochemical properties… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
65
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 117 publications
(65 citation statements)
references
References 128 publications
0
65
0
Order By: Relevance
“…Mesoporous silicon-based NMs are composed of amorphous skeletons with a high pore capacity, are uniform with an adjustable pore size, and have an available functionalization and interface effect [40]. Furthermore, this kind of material has good biocompatibility, contributing to its wide application prospects in fields of biotechnology such as drug delivery [41] and gene therapy [42,43]. The discovery of MSNs has greatly promoted the development of sustained and controlled drug release field.…”
Section: Mesoporous Silica Nms (Msns)mentioning
confidence: 99%
“…Mesoporous silicon-based NMs are composed of amorphous skeletons with a high pore capacity, are uniform with an adjustable pore size, and have an available functionalization and interface effect [40]. Furthermore, this kind of material has good biocompatibility, contributing to its wide application prospects in fields of biotechnology such as drug delivery [41] and gene therapy [42,43]. The discovery of MSNs has greatly promoted the development of sustained and controlled drug release field.…”
Section: Mesoporous Silica Nms (Msns)mentioning
confidence: 99%
“…Conclusively, with the excellent laser-induced heating properties, FS3P-A/C could be a novel promising agent for photothermal therapy. 71 Figure 6A also reveals the viability of HEK293 cells treated with NPs at different dosages. Interestingly, almost all cells were still alive at the whole range of NP concentrations, indicating that drug-loaded FS3 showed no obvious cytotoxicity toward normal cells.…”
Section: In Vitro Anticancer Efficacy Of the Various Npsmentioning
confidence: 99%
“…Among the different types of nanocarriers which were developed for applications in cancer diagnosis and treatment, inorganic nanoparticles (NPs) have emerged as versatile platforms for targeted cancer imaging and drug delivery due to their inherent physical properties which allow a variety of imaging modalities and their ability for surface modification with targeting ligands and/or caged therapeutic payloads. Seminal achievements were disclosed with mesoporous silica NPs, which are composed by inner pores suitable for the immobilization of molecular cargos and outside surface amenable to conjugation with imaging probes and caging molecules . Other promising strategies include the use of functionalized superparamagnetic iron oxide NPs for targeted magnetic resonance imaging, local thermal‐ablation of cancer cells triggered by an external magnetic field and controlled delivery of chemotherapeutics such as doxorubicin .…”
Section: Introductionmentioning
confidence: 99%